Clinical and Radiographic Evaluation of a Cross-shaped Incision Technique

Sponsor
Wen Luo (Other)
Overall Status
Completed
CT.gov ID
NCT04706078
Collaborator
(none)
55
1
24
2.3

Study Details

Study Description

Brief Summary

To evaluate a cross-shaped incision technique to thick-gingiva and thin-gingiva patients treated with implant-supported fixed prosthesis.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: The biotype of gingival

Detailed Description

Objective: To evaluate a cross-shaped incision technique to thick-gingiva and thin-gingiva patients treated with implant-supported fixed prosthesis. Methods and Materials: 55 patients received cross-shaped incision were assigned into thick-gingiva group (29 cases) and thin-gingiva group (26 cases). Follow-up examination was carried out 3 and 12 months after final restoration. Clinical and radiographic evaluation including gingival papilla height, modified plaque index, modified sulcus bleeding index, periodontal depth, and crestal marginal bone level were utilized.

Study Design

Study Type:
Observational
Actual Enrollment :
55 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Clinical and Radiographic Evaluation of a Cross-shaped Incision Technique to Thick-gingiva and Thin-gingiva Patients Treated With Implant-supported Fixed Prosthesis
Actual Study Start Date :
Jun 1, 2018
Actual Primary Completion Date :
Jun 1, 2020
Actual Study Completion Date :
Jun 1, 2020

Arms and Interventions

Arm Intervention/Treatment
thick-gingiva group

After insertion of the probe into the facial aspect of the sulcus, the peri-implant biotype can be categorized as thick-gingiva (outline if the probe cannot be seen through the gingival)

thin-gingiva group

After insertion of the probe into the facial aspect of the sulcus, the peri-implant biotype can be categorized as thin-gingiva (outline of the probe can be seen through the gingival)

Diagnostic Test: The biotype of gingival
The biotype of gingival was also determined by periodontal probe.

Outcome Measures

Primary Outcome Measures

  1. papilla height [Between June 2018 and June 2020.]

    Presence/absence of papilla height was assessed visually

  2. Modified Plaque Index (mPI) [Between June 2018 and June 2020.]

    plaque accumulation around the marginal peri-implant tissue was assessed

  3. Modified Sulcus Bleeding Index [Between June 2018 and June 2020.]

    the bleeding tendency of the marginal peri-implant tissue was evaluated

  4. Probing Depth (PD, in millimeters) [Between June 2018 and June 2020.]

    PD was assessed at the mid-buccal, mid-oral, mesial and distal aspects of each implant with a standard periodontal probe, and final value was determined by the average of four aspects

  5. Gingival margin level [Between June 2018 and June 2020.]

    Gingival margin level was assessed by calculating the vertical distance between the most apical point of gingival margin at the buccal aspect of the crown and line connecting the peak of the adjacent mesial and distal natural teeth

Secondary Outcome Measures

  1. first bone-implant contact (fBIC) and implant shoulder (IS) [Between June 2018 and June 2020.]

    the landmarks of first bone-implant contact (fBIC) and implant shoulder (IS) were used for measurements. fBIC-IS was defined as the vertical distance the first bone-implant contact to implant shoulder, and the distance was assessed at the mesial and distal aspect of implant, respectively. When the marginal crestal bone was located coronal to the IS, a positive (+) value was given, where a negative (-) value when located apically to the IS, the value was deemed as zero when IS and fBIC coincided.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Good general health, no chronic systemic diseases.

  2. All subjects included in this study needed to have one missing premolar or molar teeth with adjacent natural teeth.

  3. All subjects included in the study had been treated with one bone-level implant insertion in the premolar or molar region.

Exclusion Criteria:
  1. Active periodontal infections.

  2. Heavy smoking habit (>10 cigarettes per day).

Contacts and Locations

Locations

Site City State Country Postal Code
1 West China Hospital of Stomatology Chengdu Sichuan China 610041

Sponsors and Collaborators

  • Wen Luo

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Wen Luo, Associate Professor, West China Hospital
ClinicalTrials.gov Identifier:
NCT04706078
Other Study ID Numbers:
  • 2009033
First Posted:
Jan 12, 2021
Last Update Posted:
Jan 12, 2021
Last Verified:
Jan 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jan 12, 2021